Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

BACKGROUND: We assessed the safety and immunogenicity of the RTS,S/AS01 malaria vaccine in a subset of children identified as HIV-infected during a large phase III randomized controlled trial conducted in seven sub-Saharan African countries. METHODS: Infants 6–12 weeks and children 5–17 months old w...

Descripción completa

Detalles Bibliográficos
Autores principales: Otieno, Lucas, Mendoza, Yolanda Guerra, Adjei, Samuel, Agbenyega, Tsiri, Agnandji, Selidji Todagbe, Aide, Pedro, Akoo, Pauline, Ansong, Daniel, Asante, Kwaku Poku, Berkley, James A, Gesase, Samwel, Hamel, Mary J., Hoffman, Irving, Kaali, Seyram, Kamthunzi, Portia, Kariuki, Simon, Kremsner, Peter, Lanaspa, Miguel, Lell, Bertrand, Lievens, Marc, Lusingu, John, Malabeja, Anangisye, Masoud, Nahya Salim, Mtoro, Ali Takadir, Njuguna, Patricia, Ofori-Anyinam, Opokua, Otieno, Godfrey Allan, Otieno, Walter, Owusu-Agyei, Seth, Schuerman, Lode, Sorgho, Hermann, Tanner, Marcel, Tinto, Halidou, Valea, Innocent, Vandoolaeghe, Pascale, Sacarlal, Jahit, Oneko, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613311/
https://www.ncbi.nlm.nih.gov/pubmed/31708182
http://dx.doi.org/10.1016/j.vaccine.2019.10.077

Ejemplares similares

Ejemplares similares